Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

In vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents Against Cystic Fibrosis Respiratory Pathogens.

Caverly LJ, Spilker T, Kalikin LM, Stillwell T, Young C, Huang DB, LiPuma JJ.

Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01595-19. doi: 10.1128/AAC.01595-19. [Epub ahead of print]

PMID:
31611364
2.

Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.

Caverly LJ, Lu J, Carmody LA, Kalikin LM, Shedden K, Opron K, Azar M, Cahalan S, Foster B, VanDevanter DR, Simon RH, LiPuma JJ.

Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.

PMID:
31415187
3.

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.

Carmody LA, Caverly LJ, Foster BK, Rogers MAM, Kalikin LM, Simon RH, VanDevanter DR, LiPuma JJ.

PLoS One. 2018 Mar 9;13(3):e0194060. doi: 10.1371/journal.pone.0194060. eCollection 2018.

4.

In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli.

Mazer DM, Young C, Kalikin LM, Spilker T, LiPuma JJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00766-17. doi: 10.1128/AAC.00766-17. Print 2017 Sep.

5.

Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected wounds.

Cao Z, Spilker T, Fan Y, Kalikin LM, Ciotti S, LiPuma JJ, Makidon PE, Wilkinson JE, Baker JR Jr, Wang SH.

Nanomedicine (Lond). 2017 May;12(10):1177-1185. doi: 10.2217/nnm-2017-0025. Epub 2017 Apr 27.

PMID:
28447896
6.

Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-report.

Caverly LJ, Caverly TJ, Kalikin LM, Foster BK, Simon RH, LiPuma JJ.

J Cyst Fibros. 2016 Sep;15(5):630-3. doi: 10.1016/j.jcf.2016.04.009. Epub 2016 May 5.

7.

Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.

Caverly LJ, Carmody LA, Haig SJ, Kotlarz N, Kalikin LM, Raskin L, LiPuma JJ.

PLoS One. 2016 Apr 19;11(4):e0153876. doi: 10.1371/journal.pone.0153876. eCollection 2016.

8.

Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens.

Mahboubi MA, Carmody LA, Foster BK, Kalikin LM, VanDevanter DR, LiPuma JJ.

J Clin Microbiol. 2016 Mar;54(3):613-9. doi: 10.1128/JCM.02299-15. Epub 2015 Dec 23.

9.

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation.

Carmody LA, Zhao J, Kalikin LM, LeBar W, Simon RH, Venkataraman A, Schmidt TM, Abdo Z, Schloss PD, LiPuma JJ.

Microbiome. 2015 Apr 1;3:12. doi: 10.1186/s40168-015-0074-9. eCollection 2015.

10.

Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis.

Ramirez IA, Caverly LJ, Kalikin LM, Goldsmith AM, Lewis TC, Burke DT, LiPuma JJ, Sajjan US, Hershenson MB.

Ann Am Thorac Soc. 2014 May;11(4):554-61. doi: 10.1513/AnnalsATS.201310-346OC. Erratum in: Ann Am Thorac Soc. 2015 Jun;12(6):960. Caverly, Lindsay L [corrected to Caverly, Lindsay J].

11.

Decade-long bacterial community dynamics in cystic fibrosis airways.

Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ.

Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14. doi: 10.1073/pnas.1120577109. Epub 2012 Mar 26.

12.

Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum.

Zhao J, Carmody LA, Kalikin LM, Li J, Petrosino JF, Schloss PD, Young VB, LiPuma JJ.

PLoS One. 2012;7(3):e33127. doi: 10.1371/journal.pone.0033127. Epub 2012 Mar 8.

13.

Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens.

Zhao J, Li J, Schloss PD, Kalikin LM, Raymond TA, Petrosino JF, Young VB, LiPuma JJ.

J Clin Microbiol. 2011 Oct;49(10):3717-8. doi: 10.1128/JCM.01189-11. Epub 2011 Aug 24. No abstract available.

14.

Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus.

Patel DA, Shih YJ, Newton DW, Michael CW, Oeth PA, Kane MD, Opipari AW, Ruffin MT 4th, Kalikin LM, Kurnit DM.

J Virol Methods. 2009 Sep;160(1-2):78-84. doi: 10.1016/j.jviromet.2009.04.024. Epub 2009 May 3.

15.

In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

LiPuma JJ, Rathinavelu S, Foster BK, Keoleian JC, Makidon PE, Kalikin LM, Baker JR Jr.

Antimicrob Agents Chemother. 2009 Jan;53(1):249-55. doi: 10.1128/AAC.00691-08. Epub 2008 Oct 27.

16.

Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Peterson EA, Kalikin LM, Steels JD, Estey MP, Trimble WS, Petty EM.

Mamm Genome. 2007 Nov;18(11):796-807. Epub 2007 Oct 6.

PMID:
17922164
17.

High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.

Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM.

Cancer Res. 2007 Sep 15;67(18):8554-64.

18.

Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.

Loberg RD, Day LL, Dunn R, Kalikin LM, Pienta KJ.

Neoplasia. 2006 Jan;8(1):69-78.

19.

Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.

Loberg RD, Neeley CK, Adam-Day LL, Fridman Y, St John LN, Nixdorf S, Jackson P, Kalikin LM, Pienta KJ.

Int J Oncol. 2005 Jun;26(6):1699-705.

PMID:
15870888
20.

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ.

Urology. 2005 Mar;65(3):616-21.

PMID:
15780403
21.

Bone turnover mediates preferential localization of prostate cancer in the skeleton.

Schneider A, Kalikin LM, Mattos AC, Keller ET, Allen MJ, Pienta KJ, McCauley LK.

Endocrinology. 2005 Apr;146(4):1727-36. Epub 2005 Jan 6.

PMID:
15637291
22.

Dynamic process of prostate cancer metastasis to bone.

Tantivejkul K, Kalikin LM, Pienta KJ.

J Cell Biochem. 2004 Mar 1;91(4):706-17. Review.

23.

Prostate-specific antigen doubling time and survival in patients with advanced metastatic prostate cancer.

Loberg RD, Fielhauer JR, Pienta BA, Dresden S, Christmas P, Kalikin LM, Olson KB, Pienta KJ.

Urology. 2003 Dec 29;62 Suppl 1:128-33. Review.

PMID:
14747050
24.

In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice.

Kalikin LM, Schneider A, Thakur MA, Fridman Y, Griffin LB, Dunn RL, Rosol TJ, Shah RB, Rehemtulla A, McCauley LK, Pienta KJ.

Cancer Biol Ther. 2003 Nov-Dec;2(6):656-60.

PMID:
14688471
25.

Mutant deoxynucleotide carrier is associated with congenital microcephaly.

Rosenberg MJ, Agarwala R, Bouffard G, Davis J, Fiermonte G, Hilliard MS, Koch T, Kalikin LM, Makalowska I, Morton DH, Petty EM, Weber JL, Palmieri F, Kelley RI, Schäffer AA, Biesecker LG.

Nat Genet. 2002 Sep;32(1):175-9. Epub 2002 Aug 19.

PMID:
12185364
27.

Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.

Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, Keilty GW, Cranston AN, Weissenbach J, Hickey I, Johnston PG.

Cancer Res. 2000 Sep 1;60(17):4729-34.

29.

An integrated physical and gene map of human distal chromosome 17q24-proximal 17q25 encompassing multiple disease loci.

Kalikin LM, George RA, Keller MP, Bort S, Bowler NS, Law DJ, Chance PF, Petty EM.

Genomics. 1999 Apr 1;57(1):36-42.

PMID:
10191081
30.
31.

A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.

Kalikin LM, Frank TS, Svoboda-Newman SM, Wetzel JC, Cooney KA, Petty EM.

Oncogene. 1997 Apr 24;14(16):1991-4.

32.

Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25.

Kalikin LM, Qu X, Frank TS, Caduff RF, Svoboda SM, Law DJ, Petty EM.

Genes Chromosomes Cancer. 1996 Sep;17(1):64-8.

PMID:
8889509
33.

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

Matsuoka S, Thompson JS, Edwards MC, Bartletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP.

Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3026-30.

34.

Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments.

Hoovers JM, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillon-Miller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannens M, Feinberg AP.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12456-60.

35.

Loss of imprinting in human cancer.

Feinberg AP, Kalikin LM, Johnson LA, Thompson JS.

Cold Spring Harb Symp Quant Biol. 1994;59:357-64. No abstract available.

PMID:
7587088
36.

Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11.

Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP.

Science. 1993 Apr 16;260(5106):361-4.

PMID:
8469989
37.

Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts.

Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, Koi M, Reeve AE, Brownstein BH, Yeger H, Williams BR, et al.

Science. 1990 Nov 16;250(4983):994-7.

PMID:
2173146
38.

A genomic clone of Zfy-1 from a YDOM mouse strain detects post-meiotic gene expression of Zfy in testes.

Kalikin LM, Fujimoto H, Witt MP, Verga V, Erickson RP.

Biochem Biophys Res Commun. 1989 Dec 29;165(3):1286-91.

Supplemental Content

Loading ...
Support Center